Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

Memorial Sloan Kettering Cancer Center · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
multiple-myeloma
multiple myeloma, carfilzomib, lenalidomide, dexamethasone, daratumumab, salvage autologous hematopoietic cell transplantation, 17-493, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 892029
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.